Seeing posts about long-term progress with tirzepatide lately, and it’s genuinely heartening. I wanted to bring up a thread of the literature that I think deserves more attention in these discussions, because it reframes what ‘the medicine works’ actually means mechanistically. SURMOUNT-4 is the maintenance trial where participants who’d already lost substantial weight on tirzepatide were randomised to either continue or switch to placebo. The placebo arm regained roughly half their lost weight within a year. That’s the headline number most people know. What gets skipped is the interpretation question underneath it: does that rebound mean tirzepatide never shifted the defended weight set point, or does it mean the set point shifted but requires ongoing drug exposure to hold? Those two readings have very different implications. The first is essentially ‘tirzepatide suppresses appetite and you get hungry again when it stops.’ The second is closer to ‘tirzepatide acts on GIP and GLP-1 receptors in ways that modulate hypothalamic weight regulation, and the system reverts when the signal is withdrawn.’ Both could produce identical rebound curves, which is the frustrating part. There’s a smaller body of work looking at adipokine profiles and leptin sensitivity during and after GLP-1 class treatment that I think is underread in patient-facing discussions. Leptin resistance is part of why maintained weight loss is so hard with lifestyle changes alone, and there are hints in some of the mechanistic papers that tirzepatide’s dual agonism may affect that pathway differently than semaglutide. Whether that translates to a more durable set point change is genuinely unresolved. For people celebrating milestones after two-plus years on compounded tirzepatide, I think it’s worth sitting with the fact that the durability question is still open. Not to diminish what’s been achieved, because the clinical results are real. Just that ‘this medicine works’ and ‘we understand why it works long-term’ are two separate claims, and the literature is confident about the first and much less so about the second.